aTYR PHARMA INC
Ownership Transactions Reported by 10 Insiders
-
Symbol
-
ATYR on Nasdaq
-
Location
-
10240 Sorrento Valley Road, Suite 300, San Diego, CA
Insiders trading volume in the past year
aTYR PHARMA INC executives and other stock owners filed with the SEC include:
| Name |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Report Date |
| Paul Schimmel |
Director |
$7.48M |
|
|
Oct 8, 2025 |
| Sanjay Shukla |
President and CEO, Director |
$630K |
|
|
Feb 3, 2025 |
| Jill Marie Broadfoot |
Chief Financial Officer |
$143K |
-$4.74K |
-3.21% |
Feb 3, 2025 |
| Nancy Denyes |
General Counsel |
$117K |
-$3.4K |
-2.83% |
Feb 3, 2025 |
| Timothy Coughlin |
Director |
$98K |
|
|
May 1, 2025 |
| Jane A. Gross |
Director |
$39K |
+$15K |
+62.5% |
May 1, 2025 |
| Svetlana Lucas |
Director |
|
|
|
May 1, 2025 |
| John K. Clarke |
Director |
|
|
|
May 22, 2024 |
| Sara Zaknoen |
Director |
|
|
|
May 1, 2025 |
| Eric Benevich |
Director |
|
|
|
May 1, 2025 |
Recent Insider Transactions by Companies or Individuals for aTYR PHARMA INC
| Insider |
Symbol |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares Owned |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.